TN2013000039A1 - Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy - Google Patents
Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapyInfo
- Publication number
- TN2013000039A1 TN2013000039A1 TNP2013000039A TN2013000039A TN2013000039A1 TN 2013000039 A1 TN2013000039 A1 TN 2013000039A1 TN P2013000039 A TNP2013000039 A TN P2013000039A TN 2013000039 A TN2013000039 A TN 2013000039A TN 2013000039 A1 TN2013000039 A1 TN 2013000039A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treatment
- heart failure
- hypertension
- prevention
- receiving anti
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title abstract 3
- 229940127219 anticoagulant drug Drugs 0.000 title abstract 3
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 abstract 1
- 229960005080 warfarin Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to methods and pharmaceutical compositions for treating hypertension and/or preventing or treating heart failure in a mammal receiving anti-coagulant therapy using compound(s) which are therapeutically effective but do not impact the pharmacokinetic or the pharmacodynamic effect(s) of the anti-coagulant, such as warfarin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/048542 WO2012027237A1 (en) | 2010-08-24 | 2011-08-22 | Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000039A1 true TN2013000039A1 (en) | 2014-06-25 |
Family
ID=54360749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000039A TN2013000039A1 (en) | 2011-08-22 | 2013-01-30 | Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000039A1 (en) |
-
2013
- 2013-01-30 TN TNP2013000039A patent/TN2013000039A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500231A1 (en) | Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy | |
| MY178621A (en) | Deuterated cftr potentiators | |
| WO2012025213A3 (en) | Novel therapeutic compounds | |
| UA111841C2 (en) | BENZOTHIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATION | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| UA115983C2 (en) | Dna-pk inhibitors | |
| GB201103062D0 (en) | Method | |
| MX366955B (en) | Treatment of cancer. | |
| EA201490423A1 (en) | METHODS AND COMPOSITIONS RELATED TO p62 FOR TREATMENT AND PREVENTION OF CANCER | |
| EA201390428A1 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF PULMONARY HYPERTENSION | |
| IN2012DN03807A (en) | ||
| WO2015066426A3 (en) | Angiopoietin-based interventions for treating cerebral malaria | |
| WO2012040636A3 (en) | Compounds and methods for treating diseases mediated by protease activated receptors | |
| PH12014502558B1 (en) | Drug for preventing and/or treating polycystic kidney disease | |
| WO2011014825A3 (en) | Antiangiogenic small molecules and methods of use | |
| WO2014031732A3 (en) | Methods for inhibiting fascin | |
| GB2482817A (en) | Novel use | |
| HK1214128A1 (en) | Treatment of cancer | |
| EA201690763A1 (en) | TREATMENT OF PANCREAS CANCER | |
| WO2014149139A3 (en) | Halogenopyrazoles as inhibitors of thrombin | |
| EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
| PH12012501476A1 (en) | Aminoquinoline derivatives | |
| WO2012138653A3 (en) | Treatment regimens | |
| WO2012082942A3 (en) | Neuropeptide analogs, compositions, and methods for treating pain | |
| WO2010115741A3 (en) | New therapeutic approaches for treating neuroinflammatory conditions |